<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(2)</volume><submitter>Kang R</submitter><pubmed_abstract>The Obstetric Quality of Recovery (ObsQoR-11) score is a new scoring tool that assesses maternal recovery after cesarean section (CS). We aimed to validate the translated Korean version of ObsQoR-11 (ObsQoR-11K) after elective CS. We validated ObsQoR-11K between March 2021 to August 2021. Validity (convergent, discriminant, and construct), reliability (Cronbach's α, inter-item, split-half, and test-retest correlation), responsiveness, and clinical feasibility (recruitment rate and time for ObsQoR-11K completion) of ObsQoR-11K were evaluated. One hundred and twenty women completed the ObsQoR-11K 24 h after CS, and 24 women repeated it 25 h after CS. We found good convergent validity between the ObsQoR-11K score and the global health numerical rating scale (NRS) (ρ = 0.73 (95% CI 0.64 to 0.81); p &lt; 0.001). The ObsQoR-11K score discriminated well between good (NRS ≥ 70 mm, n = 68, 69.6 ± 13.7) and poor recovery (NRS &lt; 70 mm, n = 52, 50.6 ± 12.6, p &lt; 0.001). The ObsQoR-11K score showed acceptable internal consistency (Cronbach's α = 0.78), split-half reliability (0.89), intra-class correlation > 0.4, and no floor or ceiling effect. Of the participants, 100% completed the ObsQoR-11K and median (IQR) time for ObsQoR-11K completion was 81 s (66-97.5 s). ObsQoR-11K is a valid and reliable scoring tool for assessing maternal recovery after elective CS in Korean women.</pubmed_abstract><journal>Diagnostics (Basel, Switzerland)</journal><pagination>291</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8871019</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Validation and Clinical Utility of the Korean Version of the Obstetric Quality-of-Recovery Score (ObsQoR-11) Following Elective Cesarean Section: A Prospective Observational Cohort Study.</pubmed_title><pmcid>PMC8871019</pmcid><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Kang R</pubmed_authors><pubmed_authors>Cho YJ</pubmed_authors><pubmed_authors>Ko JS</pubmed_authors><pubmed_authors>Choi SJ</pubmed_authors><pubmed_authors>Kim DK</pubmed_authors><pubmed_authors>Sim WS</pubmed_authors><pubmed_authors>Lee E</pubmed_authors><pubmed_authors>Jeong JS</pubmed_authors><pubmed_authors>Gwak MS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation and Clinical Utility of the Korean Version of the Obstetric Quality-of-Recovery Score (ObsQoR-11) Following Elective Cesarean Section: A Prospective Observational Cohort Study.</name><description>The Obstetric Quality of Recovery (ObsQoR-11) score is a new scoring tool that assesses maternal recovery after cesarean section (CS). We aimed to validate the translated Korean version of ObsQoR-11 (ObsQoR-11K) after elective CS. We validated ObsQoR-11K between March 2021 to August 2021. Validity (convergent, discriminant, and construct), reliability (Cronbach's α, inter-item, split-half, and test-retest correlation), responsiveness, and clinical feasibility (recruitment rate and time for ObsQoR-11K completion) of ObsQoR-11K were evaluated. One hundred and twenty women completed the ObsQoR-11K 24 h after CS, and 24 women repeated it 25 h after CS. We found good convergent validity between the ObsQoR-11K score and the global health numerical rating scale (NRS) (ρ = 0.73 (95% CI 0.64 to 0.81); p &lt; 0.001). The ObsQoR-11K score discriminated well between good (NRS ≥ 70 mm, n = 68, 69.6 ± 13.7) and poor recovery (NRS &lt; 70 mm, n = 52, 50.6 ± 12.6, p &lt; 0.001). The ObsQoR-11K score showed acceptable internal consistency (Cronbach's α = 0.78), split-half reliability (0.89), intra-class correlation > 0.4, and no floor or ceiling effect. Of the participants, 100% completed the ObsQoR-11K and median (IQR) time for ObsQoR-11K completion was 81 s (66-97.5 s). ObsQoR-11K is a valid and reliable scoring tool for assessing maternal recovery after elective CS in Korean women.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2024-11-09T10:33:34.46Z</modification><creation>2024-11-09T10:33:34.46Z</creation></dates><accession>S-EPMC8871019</accession><cross_references><pubmed>35204382</pubmed><doi>10.3390/diagnostics12020291</doi></cross_references></HashMap>